Concerns growing over public health
Published: 2007-04-06 06:59:00
Updated: 2007-04-06 06:59:00
The end of the free trade agreement (FTA) will be a big blow to Korean pharmaceutical firms that rely much of the revenue on the sales of generic drugs, and also threaten the government's ability to control the prices.
Under the deal, U.S. drug makers will be able to secure longer exclusive sa...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
